Skip to content

Latest medicine updates

164 updates found

New New Updated Updated Retired Retired

NARROW IT DOWN

MEDICINE NAME

CHANGES

Date range

DOCUMENT TYPE

STATUS

Pil
donepezil hydrochloride
Updated 26-May-17
New
  • New PIL for eMC ie a PIL for an existing product but one that is new to the eMC
Pil
dexamethasone sodium phosphate
Updated 26-May-17
New
  • New PIL for eMC ie a PIL for an existing product but one that is new to the eMC
Pil
atenolol, chlortalidone
Updated 26-May-17
New
  • New PIL for eMC ie a PIL for an existing product but one that is new to the eMC
Pil
paracetamol, dihydrocodeine tartrate
Updated 26-May-17
New
  • New PIL for eMC ie a PIL for an existing product but one that is new to the eMC
Pil
fluconazole
Updated 26-May-17
New
  • New PIL for eMC ie a PIL for an existing product but one that is new to the eMC
Pil
fluconazole
Updated 26-May-17
New
  • New PIL for eMC ie a PIL for an existing product but one that is new to the eMC
Pil
aripiprazole
Updated 26-May-17
New
  • New PIL for eMC ie a PIL for an existing product but one that is new to the eMC
Pil
anastrozole
Updated 26-May-17
New
  • New PIL for eMC ie a PIL for an existing product but one that is new to the eMC
Pil
allopurinol
Updated 26-May-17
New
  • New PIL for eMC ie a PIL for an existing product but one that is new to the eMC
SPC
emtricitabine, elvitegravir, cobicistat, tenofovir alafenamide fumarate
Updated 26-May-17
Updated
  • Change to section 4.5 - Interaction with other medicinal products and other forms of interaction
  • Change to section 10 - Date of revision of the text
SPC
tenofovir disoproxil fumarate, efavirenz, emtricitabine
Updated 26-May-17
Updated
  • Change to section 4.4 - Special warnings and precautions for use
  • Change to section 4.5 - Interaction with other medicinal products and other forms of interaction
  • Change to section 10 - Date of revision of the text
Pil
nifedipine
Updated 26-May-17
Updated
  • Change to section 2 - what you need to know - contraindications
  • Change to section 2 - what you need to know - warnings and precautions
  • Change to section 2 - interactions with other medicines, food or drink
  • Change to section 2 - pregnancy, breast feeding and fertility
  • Change to section 2 - driving and using machines
  • Change to section 2 - excipient warnings
  • Change to section 3 - how to take/use
  • Change to section 3 - overdose, missed or forgotten doses
  • Change to section 4 - possible side effects
  • Change to section 6 - date of revision
Pil
human normal immunoglobulin
Updated 26-May-17
Updated
  • Change to section 2 - what you need to know - warnings and precautions
  • Change to section 3 - how to take/use
Pil
Pregabalin Accord 25 mg,50 mg,75 mg,100 mg,150mg,200 mg,225 mg,300 mg hard capsules
pregabalin
Retired 26-May-17
Accord Healthcare Limited
Retired
  • Submitted in error
SPC
Pregabalin Accord 25 mg, 50mg, 75mg,100 mg,150 mg,200 mg, 225 mg,300 mg hard capsules
pregabalin
Retired 26-May-17
Accord Healthcare Limited
Retired
  • Submitted in error
Pil
losartan potassium
Updated 26-May-17
Updated
  • Change to section 6 - date of revision
  • Correction of spelling/typing errors
Pil
losartan potassium
Updated 26-May-17
Updated
  • Change to section 6 - date of revision
  • Correction of spelling/typing errors
Pil
human normal immunoglobulin
Updated 26-May-17
Updated
  • Change to section 3 - how to take/use
  • Change to section 4 - possible side effects
SPC
bosentan monohydrate
Updated 26-May-17
Updated
  • Correction of spelling/typing errors
SPC
doxazosin mesilate
Updated 26-May-17
New
  • New SPC for eMC ie an SPC for an existing product, but one that is new for the eMC
SPC
doxazosin mesilate
Updated 26-May-17
New
  • New SPC for eMC ie an SPC for an existing product, but one that is new for the eMC
SPC
doxazosin mesilate
Updated 26-May-17
New
  • New SPC for eMC ie an SPC for an existing product, but one that is new for the eMC
SPC
diclofenac sodium
Updated 26-May-17
New
  • New SPC for eMC ie an SPC for an existing product, but one that is new for the eMC
SPC
diclofenac sodium
Updated 26-May-17
New
  • New SPC for eMC ie an SPC for an existing product, but one that is new for the eMC
SPC
diclofenac sodium
Updated 26-May-17
New
  • New SPC for eMC ie an SPC for an existing product, but one that is new for the eMC
SPC
diclofenac sodium
Updated 26-May-17
New
  • New SPC for eMC ie an SPC for an existing product, but one that is new for the eMC
SPC
posaconazole
Updated 26-May-17
Updated
  • Change to section 4.4 - Special warnings and precautions for use
  • Change to section 4.5 - Interaction with other medicinal products and other forms of interaction
SPC
posaconazole
Updated 26-May-17
Updated
  • Change to section 4.4 - Special warnings and precautions for use
  • Change to section 4.5 - Interaction with other medicinal products and other forms of interaction
SPC
posaconazole
Updated 26-May-17
Updated
  • Change to section 4.4 - Special warnings and precautions for use
  • Change to section 4.5 - Interaction with other medicinal products and other forms of interaction
Pil
pholcodine
Updated 26-May-17
Updated
  • Change to section 5 - how to store or dispose
SPC
neomycin sulfate, chlorhexidine dihydrochloride
Updated 26-May-17
Updated
  • Change to section 6.5 - Nature and contents of container
Pil
epoprostenol sodium
Updated 26-May-17
Updated
  • Change to section 6 - date of revision
Pil
epoprostenol sodium
Updated 26-May-17
Updated
  • Change to section 6 - date of revision
SPC
phenytoin
Updated 26-May-17
Updated
  • Change to section 4.2 - Posology and method of administration
  • Change to section 4.3 - Contraindications
  • Change to section 4.4 - Special warnings and precautions for use
  • Change to section 4.6 - Fertility, pregnancy and lactation
  • Change to section 4.8 - Undesirable effects - how to report a side effect
  • Change to section 5.2 - Pharmacokinetic properties
  • Change to section 6.2 - Incompatibilities
SPC
levetiracetam
Updated 26-May-17
New
  • New SPC for eMC ie an SPC for an existing product, but one that is new for the eMC
SPC
allopurinol
Updated 26-May-17
New
  • New SPC for eMC ie an SPC for an existing product, but one that is new for the eMC
SPC
Revlimid 7.5mg
lenalidomide
Retired 26-May-17
Celgene Ltd
Retired
  • Individual SPC superseded by joint SPC
SPC
Revlimid 10mg
lenalidomide
Retired 26-May-17
Celgene Ltd
Retired
  • Individual SPC superseded by joint SPC
SPC
Revlimid 5mg
lenalidomide
Retired 26-May-17
Celgene Ltd
Retired
  • Individual SPC superseded by joint SPC
SPC
Revlimid 15mg
lenalidomide
Retired 26-May-17
Celgene Ltd
Retired
  • Individual SPC superseded by joint SPC
SPC
Revlimid 20 mg hard capsules
lenalidomide
Retired 26-May-17
Celgene Ltd
Retired
  • Individual SPC superseded by joint SPC
SPC
Revlimid 25mg
lenalidomide
Retired 26-May-17
Celgene Ltd
Retired
  • Individual SPC superseded by joint SPC
SPC
pholcodine
Updated 26-May-17
Updated
  • Change to section 6.4 - Special precautions for storage
Pil
ramipril
Updated 26-May-17
Updated
  • Change to section 2 - what you need to know - warnings and precautions
  • Change to section 2 - interactions with other medicines, food or drink
  • Change to section 2 - pregnancy, breast feeding and fertility
  • Change to section 4 - possible side effects
Pil
Prednisolone 5mg Suppositories
prednisolone sodium phosphate
Retired 25-May-17
Concordia International- formerly Focus Pharmaceuticals Ltd
Retired
  • Transfer of Marketing Authorisation Holder
SPC
Prednisolone 5mg Suppositories
prednisolone sodium phosphate
Retired 25-May-17
Concordia International- formerly Focus Pharmaceuticals Ltd
Retired
  • Transfer of Marketing Authorisation Holder
SPC
decitabine
Updated 25-May-17
Updated
  • Change to section 2 - Qualitative and quantitative composition
  • Change to section 4.2 - Posology and method of administration
  • Change to section 4.4 - Special warnings and precautions for use
  • Change to section 4.5 - Interaction with other medicinal products and other forms of interaction
  • Change to section 4.6 - Fertility, pregnancy and lactation
  • Change to section 4.7 - Effects on ability to drive and use machines
  • Change to section 6.5 - Nature and contents of container
  • Change to section 6.6 - Special precautions for disposal and other handling
  • Change to section 9 - Date of first authorisation/renewal of the authorisation
  • Change to section 10 - Date of revision of the text
SPC
sunitinib malate
Updated 25-May-17
Updated
  • Change to section 4.1 - Therapeutic indications
  • Change to section 5.1 - Pharmacodynamic properties
SPC
phenytoin sodium
Updated 25-May-17
Updated
  • Change to section 4.2 - Posology and method of administration
  • Change to section 4.3 - Contraindications
  • Change to section 4.4 - Special warnings and precautions for use
  • Change to section 4.6 - Fertility, pregnancy and lactation
  • Change to section 4.8 - Undesirable effects - how to report a side effect
  • Change to section 5.2 - Pharmacokinetic properties
  • Change to section 6.2 - Incompatibilities
SPC
phenytoin
Updated 25-May-17
Updated
  • Change to section 4.2 - Posology and method of administration
  • Change to section 4.3 - Contraindications
  • Change to section 4.4 - Special warnings and precautions for use
  • Change to section 4.6 - Fertility, pregnancy and lactation
  • Change to section 4.8 - Undesirable effects - how to report a side effect
  • Change to section 5.2 - Pharmacokinetic properties
  • Change to section 6.2 - Incompatibilities

Page 1 of 4 Next

This site uses cookies. By continuing to browse the site you are agreeing to our policy on the use of cookies. Continue